BPI Chief Says EU Not Crisis-Ready on Drug Supply, Cites CMA Delay
Brussels – November 04, 2026 -- The head of Germany's pharmaceutical industry association BPI has said the EU is not prepared for a health crisis, calling European and national policy inadequate for the current geopolitical tensions.
BPI Chairman Oliver Kirst made the remarks at the association's autumn reception at the Bibliothèque Solvay in Brussels. He described the lack of crisis resilience as irresponsible and said EU action is too slow and too bureaucratic.
Critical Medicines Act still awaits formal adoption
Kirst named the Critical Medicines Act (CMA) as the prime example of EU hesitation. He called its aim of returning critical medicine production to Europe right and urgent. The act, he noted, has been debated for a long time and still has to be formally adopted.
Chairman lists open questions on production, storage and protection
Kirst said too many questions remain unanswered: